Table 1.
Characteristic | Group 1 (Limited tissue on excision) |
Group 2 (Primary surgery vs neoadjuvant therapy) |
Group 3 (Neoadjuvant chemoendocrine vs endocrine) |
P value |
---|---|---|---|---|
Age (years) | 0.38 | |||
Mean (SD) | 52.5 (8.7) | 58.9 (11.9) | 58.5 (9.3) | |
Histologic type | 0.20 | |||
Ductal | 3 | 29 | 19 | |
Lobular | 2 | 6 | 10 | |
Mixed ductal and lobular features | 1 | 1 | 6 | |
Clinical T stage | 0.01 | |||
T1 | 6 | 14 | 6 | |
T2 | 0 | 19 | 22 | |
T3 | 0 | 1 | 5 | |
T4 | 0 | 1 | 1 | |
Clinical node status | 0.08 | |||
Negative | 6 | 29 | 22 | |
Positive | 0 | 5 | 12 | |
Clinical prognostic stage | 0.06 | |||
IA | 6 | 11 | 6 | |
IB | 0 | 21 | 20 | |
IIA | 0 | 2 | 6 | |
IIIA/B | 0 | 2 | 2 | |
IV | 0 | 1 | 0 | |
Nottingham grade | 0.83 | |||
1 | 1 | 6 | 7 | |
2 | 4 | 27 | 22 | |
3 | 1 | 3 | 6 | |
Oncotype RS (original criteria) | 0.05 | |||
Low | 3 | 15 | 23 | |
Intermediate | 3 | 18 | 6 | |
High | 0 | 4 | 6 | |
Oncotype RS (TRAILORx criteria) | ||||
Low | 1 | 6 | 7 | |
Intermediate | 5 | 22 | 20 | |
High | 0 | 9 | 8 |